carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide

C42H31N5Pt — CID 140804303

IUPACcarbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide
SMILES[Pt+2].c1ccc(C2(c3cccc(-c4[n-]nc5c4CCCC5)n3)c3ccccc3-c3ccccc32)nc1.c1ccc2c(c1)[n-]c1ccccc12
InChIInChI=1S/C30H23N4.C12H8N.Pt/c1-4-13-23-20(10-1)21-11-2-5-14-24(21)30(23,27-17-7-8-19-31-27)28-18-9-16-26(32-28)29-22-12-3-6-15-25(22)33-34-29;1-3-7-11-9(5-1)10-6-2-4-8-12(10)13-11;/h1-2,4-5,7-11,13-14,16-19H,3,6,12,15H2;1-8H;/q2*-1;+2
InChIKeyRVVIWEIJGLXUJW-UHFFFAOYSA-N
MW800.82 g/mol
LogP8.69
Rot. Bonds3

About carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide

carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide (PubChem CID 140804303) has the molecular formula C42H31N5Pt and a molecular weight of 800.82 g/mol. Its IUPAC name is carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide.

Molecular Properties

Compound Namecarbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide
PubChem CID140804303
Molecular FormulaC42H31N5Pt
Molecular Weight800.82 g/mol
Exact Mass800.22
IUPAC Namecarbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide
SMILES[Pt+2].c1ccc(C2(c3cccc(-c4[n-]nc5c4CCCC5)n3)c3ccccc3-c3ccccc32)nc1.c1ccc2c(c1)[n-]c1ccccc12
InChIInChI=1S/C30H23N4.C12H8N.Pt/c1-4-13-23-20(10-1)21-11-2-5-14-24(21)30(23,27-17-7-8-19-31-27)28-18-9-16-26(32-28)29-22-12-3-6-15-25(22)33-34-29;1-3-7-11-9(5-1)10-6-2-4-8-12(10)13-11;/h1-2,4-5,7-11,13-14,16-19H,3,6,12,15H2;1-8H;/q2*-1;+2
InChIKeyRVVIWEIJGLXUJW-UHFFFAOYSA-N
XLogP8.69
TPSA66.87 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds3
Heavy Atoms48
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500800.82
LogP ≤ 58.69
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Analyze carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

carbazol-9-ide;7,7-dimethyl-3-[6-(5-pyridin-2-ylbenzo[b][1]benzosilol-5-yl)-2-pyridinyl]-5,6-dihydro-4H-indazol-2-ide;platinum(2+)
CID 140804450
dichloromethane;platinum(2+);2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]-6-[9-[6-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]-2-pyridinyl]fluoren-9-yl]pyridine
CID 139143108
2-[3-phenyl-5-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]phenyl]phenol
CID 140806096
2-(4-tert-butyl-2-pyridinyl)-6-[9-[6-(4-tert-butyl-2-pyridinyl)-2-pyridinyl]fluoren-9-yl]pyridine
CID 162425382
2-(3-tert-butylbenzene-6-id-1-yl)-6-[9-[6-(3-tert-butylbenzene-6-id-1-yl)-2-pyridinyl]fluoren-9-yl]pyridine;2-(3,4-dimethylbenzene-6-id-1-yl)-6-[9-[6-(3,4-dimethylbenzene-6-id-1-yl)-2-pyridinyl]fluoren-9-yl]pyridine;platinum;bis(platinum(2+));2-pyridin-2-yl-6-[9-(6-pyridin-2-yl-2-pyridinyl)fluoren-9-yl]pyridine
CID 158029976
12-phenyl-12-pyridin-2-yl-5H-indeno[1,2-c]carbazole
CID 135176976
2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide
CID 159944813
2-bromo-6-[14-(6-bromo-2-pyridinyl)-14-tetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),2,4,6,8,10,12,15,17-nonaenyl]pyridine
CID 89409708
2-(3-tert-butylpyrazol-1-id-5-yl)-6-(5-pyridin-2-ylbenzo[b][1]benzosilol-5-yl)pyridine;carbazol-9-ide;platinum(2+)
CID 140804358
2-(4-spiro[benzo[a]phenalene-7,9'-fluorene]-3-ylphenyl)pyridine
CID 155460562
2,4-diphenyl-6-(9-phenyl-9-pyridin-2-ylfluoren-3-yl)pyrimidine
CID 142384952
2-phenyl-6-[9-(6-phenyl-2-pyridinyl)-10H-anthracen-9-yl]pyridine
CID 71261610

Frequently Asked Questions

What is the IUPAC name of carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide?
The IUPAC name of carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide (CID 140804303) is carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide.
What is the SMILES notation for carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide?
The canonical SMILES for carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide is [Pt+2].c1ccc(C2(c3cccc(-c4[n-]nc5c4CCCC5)n3)c3ccccc3-c3ccccc32)nc1.c1ccc2c(c1)[n-]c1ccccc12.
What is the InChIKey of carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide?
The InChIKey is RVVIWEIJGLXUJW-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H23N4.C12H8N.Pt/c1-4-13-23-20(10-1)21-11-2-5-14-24(21)30(23,27-17-7-8-19-31-27)28-18-9-16-26(32-28)29-22-12-3-6-15-25(22)33-34-29;1-3-7-11-9(5-1)10-6-2-4-8-12(10)13-11;/h1-2,4-5,7-11,13-14,16-19H,3,6,12,15H2;1-8H;/q2*-1;+2.
What are the key properties of carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide?
carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide has a molecular weight of 800.82 g/mol, XLogP of 8.69, 3 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for carbazol-9-ide;platinum(2+);3-[6-(9-pyridin-2-ylfluoren-9-yl)-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide is sourced from PubChem (CID 140804303), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).